|
Volumn 61, Issue 16, 2001, Pages 6194-6200
|
Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
INTERLEUKIN 13;
INTERLEUKIN 13 RECEPTOR;
PSEUDOMONAS EXOTOXIN;
RECOMBINANT INTERLEUKIN 13;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER RISK;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
IMMUNE DEFICIENCY;
INTERNALIZATION;
LIGAND BINDING;
NUDE MOUSE;
PRIORITY JOURNAL;
ADP RIBOSE TRANSFERASES;
ANIMALS;
BACTERIAL TOXINS;
CARCINOMA, SQUAMOUS CELL;
EXOTOXINS;
HEAD AND NECK NEOPLASMS;
HUMANS;
INTERLEUKIN-13;
INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT;
MICE;
MICE, NUDE;
RECEPTORS, INTERLEUKIN;
RECEPTORS, INTERLEUKIN-13;
RECOMBINANT FUSION PROTEINS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
VIRULENCE FACTORS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035881289
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (78)
|
References (31)
|